Swiss BioQuant A.G., Switzerland   Report issue

For profit Phase 1
Founded: Reinach Switzerland (2008)

Organization Overview

First Clinical Trial
2018
NCT03707041
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Swiss BioQuant A.G., Switzerland